EGFR and metastatic malignant neoplasm in the lymph nodes: Furthermore, we found that the increased expression of EGFR protein was more frequent in lymph node metastasis of NSCLC compared to non-metastatic NSCLCs (27 vs. 14 or 45 % vs. 23.3 %; P = 0.009).